相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is D-Cycloserine a Prodrug for D-Serine in the Brain?
Mao Horio et al.
BIOLOGICAL PSYCHIATRY (2013)
A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2013)
Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice
Mao Horio et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2013)
Cognitive impairment in major depression and the mGlu2 receptor as a therapeutic target
Celia Goeldner et al.
NEUROPHARMACOLOGY (2013)
mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
Shigeyuki Chaki et al.
NEUROPHARMACOLOGY (2013)
GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
Jeffrey Burgdorf et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Sigma-1 receptor chaperone and brain-derived neurotrophic factor: Emerging links between cardiovascular disease and depression
Kenji Hashimoto
PROGRESS IN NEUROBIOLOGY (2013)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2013)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Evaluation of the Effects of Bitopertin (RG1678) on Cardiac Repolarization: A Thorough Corrected QT Study in Healthy Male Volunteers
Carsten Hofmann et al.
CLINICAL THERAPEUTICS (2012)
A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
Lobna Ibrahim et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Metabotropic glutamate receptors as therapeutic targets for schizophrenia
Paige N. Vinson et al.
NEUROPHARMACOLOGY (2012)
Glycine reuptake inhibitor RG1678: A pharmacologic characterization of an investigational agent for the treatment of schizophrenia
Daniela Alberati et al.
NEUROPHARMACOLOGY (2012)
From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
Bita Moghaddam et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Role of Serine Racemase in Behavioral Sensitization in Mice after Repeated Administration of Methamphetamine
Mao Horio et al.
PLOS ONE (2012)
Glutamate signaling in the pathophysiology and therapy of schizophrenia
Chieh-Hsin Lin et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Roles of glutamate signaling in preclinical and/or mechanistic models of depression
Kenichi Tokita et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2012)
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
Daniel C. Javitt et al.
SCHIZOPHRENIA BULLETIN (2012)
Plasma levels of D-serine in Brazilian individuals with schizophrenia
Marilia A. Calcia et al.
SCHIZOPHRENIA RESEARCH (2012)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
Alkomiet Hasan et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2012)
Serine racemase and the serine shuttle between neurons and astrocytes
Herman Wolosker
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2011)
Glutamate N-methyl-D-aspartate Receptor Antagonists Rapidly Reverse Behavioral and Synaptic Deficits Caused by Chronic Stress Exposure
Nanxin Li et al.
BIOLOGICAL PSYCHIATRY (2011)
Targeting of Metabotropic Glutamate Receptors for the Treatment of Schizophrenia
Shigeyuki Chaki et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Recent Advances in the Discovery of D-Amino Acid Oxidase Inhibitors and Their Therapeutic Utility in Schizophrenia
Dana V. Ferraris et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Glycine Transporter-1: A New Potential Therapeutic Target for Schizophrenia
Kenji Hashimoto
CURRENT PHARMACEUTICAL DESIGN (2011)
Characterization of an mGluR2/3 Negative Allosteric Modulator in Rodent Models of Depression
Brice Campo et al.
JOURNAL OF NEUROGENETICS (2011)
Levels of D-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice
Mao Horio et al.
NEUROCHEMISTRY INTERNATIONAL (2011)
Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists
Hiroyuki Koike et al.
NEUROPHARMACOLOGY (2011)
A novel NMDA receptor glycine-site partial agonist, GLYX-13, has therapeutic potential for the treatment of autism
Joseph R. Moskal et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Corticotropin-Releasing Hormone, Glutamate, and γ-Aminobutyric Acid in Depression
Shang-Feng Gao et al.
NEUROSCIENTIST (2011)
The role of glutamate on the action of antidepressants
Kenji Hashimoto
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Colleen M. Niswender et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
N-methyl-D-aspartate Glutamate Receptor Antagonists and the Promise of Rapid-Acting Antidepressants
John H. Krystal
ARCHIVES OF GENERAL PSYCHIATRY (2010)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
Guochuan E. Tsai et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Cognition and depression: the effects of fluvoxamine, a sigma-1 receptor agonist, reconsidered
Ian Hindmarch et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2010)
A randomized, double-blind, placebo-controlled comparison study of sarcosine (N-methylglycine) and D-serine add-on treatment for schizophrenia
Hsien-Yuan Lane et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Selective GlyT1 Inhibitors: Discovery of [4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl]-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a Promising Novel Medicine To Treat Schizophrenia
Emmanuel Pinard et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
The neurobiology of D-amino acid oxidase and its involvement in schizophrenia
L. Verrall et al.
MOLECULAR PSYCHIATRY (2010)
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Stephen F. Traynelis et al.
PHARMACOLOGICAL REVIEWS (2010)
Brain-derived neurotrophic factor as a biomarker for mood disorders: An historical overview and future directions
Kenji Hashimoto
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2010)
High dose D-serine in the treatment of schizophrenia
Joshua T. Kantrowitz et al.
SCHIZOPHRENIA RESEARCH (2010)
mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Nanxin Li et al.
SCIENCE (2010)
Glutamatergic Modulators: The Future of Treating Mood Disorders?
Carlos Zarate et al.
HARVARD REVIEW OF PSYCHIATRY (2010)
Co-Administration of a D-Amino Acid Oxidase Inhibitor Potentiates the Efficacy of D-Serine in Attenuating Prepulse Inhibition Deficits After Administration of Dizocilpine
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2009)
Emerging role of glutamate in the pathophysiology of major depressive disorder
Kenji Hashimoto
BRAIN RESEARCH REVIEWS (2009)
Mechanism of differential control of NMDA receptor activity by NR2 subunits
Marc Gielen et al.
NATURE (2009)
Glutamate-based antidepressants: 20 years on
Phil Skolnick et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Sarcosine (N-Methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2008)
Abnormal Glutamatergic Neurotransmission and Neuronal-Glial Interactions in Acute Mania
Dost Oenguer et al.
BIOLOGICAL PSYCHIATRY (2008)
Cellular mechanisms underlying the antidepressant effects of ketamine:: Role of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors
Sungho Maeng et al.
BIOLOGICAL PSYCHIATRY (2008)
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
Sheldon H. Preskorn et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Synthesis and biological evaluation of D-amino acid oxidase inhibitors
Dana Ferraris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
NMDA- and β-Amyloid1-42-Induced Neurotoxicity Is Attenuated in Serine Racemase Knock-Out Mice
Ran Inoue et al.
JOURNAL OF NEUROSCIENCE (2008)
Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039)
Matthew J. Fell et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Gerard Sanacora et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Increased levels of glutamate in brains from patients with mood disorders
Kenji Hashimoto et al.
BIOLOGICAL PSYCHIATRY (2007)
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil et al.
NATURE MEDICINE (2007)
A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia
Inna Bendikov et al.
SCHIZOPHRENIA RESEARCH (2007)
NMDA receptor subunits: function and pharmacology
Pierre Paoletti et al.
CURRENT OPINION IN PHARMACOLOGY (2007)
Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice
Xia Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to clozapine for the treatment of schizophrenia
Hsien-Yuan Lane et al.
BIOLOGICAL PSYCHIATRY (2006)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder
Uriel Heresco-Levy et al.
JOURNAL OF AFFECTIVE DISORDERS (2006)
D-alanine added to antipsychotics for the treatment of schizophrenia
GE Tsai et al.
BIOLOGICAL PSYCHIATRY (2006)
A double-blind, placebo-controlled study of memantine in the treatment of major depression
CA Zarate et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
GLYX-13:: A monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator
JR Moskal et al.
NEUROPHARMACOLOGY (2005)
Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia - A randomized, double-blind, placebo-controlled study
HY Lane et al.
ARCHIVES OF GENERAL PSYCHIATRY (2005)
Beyond monoamines: Glutamatergic function in mood disorders
A Kugaya et al.
CNS SPECTRUMS (2005)
Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels
K Yamada et al.
BIOLOGICAL PSYCHIATRY (2005)
Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients
K Hashimoto et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2005)
N-methyl-D-aspartate receptors as a target for improved antipsychotic agents:: novel insights and clinical perspectives
MJ Millan
PSYCHOPHARMACOLOGY (2005)
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
JH Krystal et al.
PSYCHOPHARMACOLOGY (2005)
D-serine efficacy as add-on pharmacotherapy to risperidone and olanzapine for treatment-refractory schizophrenia
U Heresco-Levy et al.
BIOLOGICAL PSYCHIATRY (2005)
Dysfunction of Glia-Neuron Communication in Pathophysiology of Schizophrenia
Kenji Hashimoto et al.
CURRENT PSYCHIATRY REVIEWS (2005)
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
PJ Harrison et al.
MOLECULAR PSYCHIATRY (2005)
Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis
HJ Tuominen et al.
SCHIZOPHRENIA RESEARCH (2005)
Critical role of brain-derived neurotrophic factor in mood disorders
K Hashimoto et al.
BRAIN RESEARCH REVIEWS (2004)
Glycine transporter I inhibitor, N-methylglycine (Sarcosine), added to antipsychotics for the treatment of schizophrenia
GC Tsai et al.
BIOLOGICAL PSYCHIATRY (2004)
MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity
S Chaki et al.
NEUROPHARMACOLOGY (2004)
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis
U Heresco-Levy et al.
SCHIZOPHRENIA RESEARCH (2004)
The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia
JT Coyle et al.
PSYCHOPHARMACOLOGY (2004)
The therapeutic potential of glycine transporter-1 inhibitors
C Sur et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Decreased serum levels of D-serine in patients with schizophrenia - Evidence in support of the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
K Hashimoto et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Neurocognitive impairment in drug-free patients with major depressive disorder
RJ Porter et al.
BRITISH JOURNAL OF PSYCHIATRY (2003)
Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia
I Chumakov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits
JE Chatterton et al.
NATURE (2002)
分享论文
